A Prospective Observational Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab

Trial Profile

A Prospective Observational Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Dec 2017

At a glance

  • Drugs Omalizumab (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Acronyms PROSPERO
  • Sponsors Roche
  • Most Recent Events

    • 17 Oct 2017 Results assessing disease and comorbidity burden characteristics published in the Annals of Allergy, Asthma and Immunology
    • 24 May 2017 Results presented at the 113th International Conference of the American Thoracic Society
    • 24 May 2017 Results assessing decreased exacerbations and hospitilizations in adolescent enrolled in PROSPERO presented at the 113th International Conference of the American Thoracic Society
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top